Innara Health has closed a funding round of $3.7 million, including investments from Open Prairie Ventures, the Kansas Bioscience Authority (KBA) and Flyover Capital.
Innara Health is a global leader in developing new neonatal medical products. Innara Health’s first product, the NTrainer System, assesses and develops non‐nutritive suck (NNS) in infants and newborns born prematurely. NNS is an essential building block for a baby’s ability to orally feed. Failure to transition to oral feeding has been shown to slow weight gain and increase length of stay for neonatal patients. The NTrainer System is in use today in hospitals across the United States.
The investment by these venture capital firms, along with investments from angel investors, has allowed the company to expand its sales and marketing team, including hiring Wendy Slatery as executive vice president of sales and marketing. Slatery, who was most recently a marketing executive with GE Healthcare, will lead the company’s sales efforts.
“Investments from these prestigious organizations are a valuable boost for our growing company,” said Bill Lomicka, chairman of the board for Innara Health. “The investments signify great confidence in our management team and our mission to improve feeding outcomes for neonatal patients. Open Prairie Ventures and the KBA have been with us since the beginning, and we are pleased to welcome Flyover Capital to help us close the fund.”
“We are thrilled to be a part of Innara Health’s funding round,” said Tom DeBacco, general partner at Flyover Capital. “This investment is a great example of Flyover Capital’s investment approach to help build innovative technology companies and support strong Midwest entrepreneurs and teams.”